Trials / Unknown
UnknownNCT03057171
A Study on the Gastrointestinal Disease and Helicobacter Pylori Controlled Long Non-coding RNA
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Yonsei University · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
Helicobacter pylori (H.pylori) is a major human pathogenic bacterium in gastric mucosa which is linked to the development of gastritis, peptic ulcer disease, mucosa-associated lymphoid tissue lymphoma and gastric cancer. However the regulatory mechanism of H.pylori-induced immune response is not clear. Long non-coding RNA (lncRNA) has recently emerged as key post-transcriptional regulators of gene expression, differentiation. The investigators had a preliminary results which THRIL (TNFα and hnRNPL related immunoregulatory lincRNA) and PACER(p50-associated COX-2 extragenic RNA) played a potential role in H.pylori induced inflammatory cascade. However, there wasn't a previous study about expression of THRIL, PACER in a human tissue. Therefore, the investigators aimed to evaluate the expression of THRIL, PACER in patients with gastrointestinal disease according to H.pylori infection.
Conditions
Timeline
- Start date
- 2015-05-01
- Primary completion
- 2020-04-01
- Completion
- 2020-04-01
- First posted
- 2017-02-17
- Last updated
- 2019-03-18
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03057171. Inclusion in this directory is not an endorsement.